¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

½ÉÀå´ë»çÁõÈıºÇÐȸ 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(1ÀÏÂ÷) : 2022-04-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
½ÉÀå´ë»çÁõÈıºÇÐȸ 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(1ÀÏÂ÷) : 2022-04-29
±³À°ÀÏÀÚ : 2022-04-29
±³À°Àå¼Ò : Conrad Hotel Seoul (5F PARK BALLROOM)  
±³À°ÁÖÁ¦ : 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå´ë»çÁõÈıºÇÐȸ  
´ã´çÀÚ : ±è¼±¿Á
¿¬¶ôó : 02-2273-8556  
À̸ÞÀÏ : apcms@kscms.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í Á¶±â»çÀüµî·Ï/Á¤±Ô»çÀüµî·Ï/ÇöÀåµî·Ï(Foreign:50USD)(Domestic M.D. / Ph.D.:180,000/190,000/200,000 KRW)(Domestic Student/Nurse/Medical Representatives/Resident, etc.:30,000KRW)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-29 Room 1 09:00~09:16 Associations Between Body Fat Parameters and Arterial Stiffness  ±èÇзÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 09:16~09:32 Predictors of Metabolic Syndrome in Patients With RA: Clinic Based Case-Control Study  Shukhrat Ziyadullaev(Samarkand State Medical Inst. Uzbekistan) 
±³À°½Ã°£ 04-29 Room 1 09:32~09:48 Knowledge, Attitude, Practice and Awareness on Complications of Hypertension Among Students and Staff in Faculty of Medicine and Health Sciences  Navin Kumar Devara(Univ. Putra Malaysia Malaysia) 
±³À°½Ã°£ 04-29 Room 1 09:48~10:04 Effects of Zinc Oxide Nanoparticles on Oxidative Stress and Renal Function in Fat-Fed and Streptozotocin-Treated Rats  Pardeep Kumar(F H Medical College India) 
±³À°½Ã°£ 04-29 Room 1 10:04~10:20 Hemo-Metabolic Crisis in Patients With ST-Segment Elevation Myocardial Infarction Data From INTERSTELLA Registry  °ø¹Î±Ô(¼øõÇâÀÇ´ë) 
Åä·Ð 04-29 Room 1 10:20~10:40 Discussion  ¿À±Ôö(Ä«Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 11:00~11:20 PCSK9 Inhibitors  ±âÀ¯Á¤(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 11:20~11:40 Recent Insights of SGLT2 Inhibitors in the Care of Cardiometabolic Syndrome  Atsushi Tanaka(Saga Univ. Japan) 
±³À°½Ã°£ 04-29 Room 1 11:40~11:50 GLP-1RA  ±è¿øÁø(Â÷ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 04-29 Room 1 11:50~12:00 ARNI  ¹ÚÁøÁÖ(¼­¿ïÀÇ´ë) 
Åä·Ð 04-29 Room 1 12:00~12:20 Discussion  ¹®Àαâ(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 13:25~14:05 New Approaches to Treating Metabolic Diseases and CVD Based on Clinical Trials  Robert H. Eckel(Univ. of Colorado USA) 
Åä·Ð 04-29 Room 1 14:05~14:25 Q&A  Robert H. Eckel(Univ. of Colorado USA) 
±³À°½Ã°£ 04-29 Room 1 14:30~14:45 Statin  À̹ÎÈ£(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 14:45~15:00 PCSK-9 Inhibitors  ÃÖ¼ºÈÆ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 15:00~15:15 Ezetimibe  Á¤ÀçÈÆ(±¹¸³Áß¾ÓÀÇ·á¿ø) 
±³À°½Ã°£ 04-29 Room 1 15:15~15:30 Colchicine  ¹ÚÈÆÁØ(°¡Å縯ÀÇ´ë) 
Åä·Ð 04-29 Room 1 15:30~15:45 Discussion  ±âÀ¯Á¤(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 16:00~16:40 Remnant Cholesterol  B©ªrge Nordestgaard(Univ. of Copenhagen Denmark) 
Åä·Ð 04-29 Room 1 16:40~16:45 Q&A  B©ªrge Nordestgaard(Univ. of Copenhagen Denmark) 
±³À°½Ã°£ 04-29 Room 1 16:50~17:05 Home BP Monitoring  ¹ÚÀçÇü(Ãæ³²´ë) 
±³À°½Ã°£ 04-29 Room 1 17:05~17:20 Management of Young Age Hypertension  ±èÇöâ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 17:20~17:35 Thiazide vs Thiazide-Like: Which Diuretic Should We Choose?  ¾ÈÈ¿¼®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 17:35~17:50 Digital therapy on hypertension  ÀÌÇØ¿µ(¼­¿ïÀÇ´ë) 
Åä·Ð 04-29 Room 1 17:50~18:05 Discussion  ±è¹Î°ü(¿¬¼¼ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ½ÉÀå´ë»çÁõÈıºÇÐȸ 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(1ÀÏÂ÷) : 2022-04-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°ñÀýÇÐȸ Á¦48Â÷ Çмú´ëȸ(1ÀÏÂ÷) : 2022-04-29
´ÙÀ½±Û (¿Â¶óÀÎ) 2022 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2022-04-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
301 ¼­¿ï Á¦4ȸ ´ëÇѽŰæ¿Ü°úº´¿øÇùÀÇȸ Çмú´ëȸ : 2018-08-19 0 1,239 2018-08-08
300 ¼­¿ï ´ëÇѳëÀκ´ÇÐȸ Á¦ 38Â÷ ÀÎÁ¤ÀÇ ¿¬¼ö°­Á : 2018-08-19 0 727 2018-08-08
299 ¼­¿ï 2018 ÀÇ·áÄ¿¹Â´ÏÄÉÀÌ¼Ç ±³À°Àü·« ¿öÅ©¼ó : 2018-08-18 0 505 2018-08-08
298 °æ±â ´ëÇÑôÃßÁ¾¾ç¿¬±¸È¸ Á¦18Â÷ Çмú´ëȸ : 2018-08-18 0 991 2018-08-08
297 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ iTHA (Innovation & Technology in Hip Athroplasty) : 2018-08-18 0 1,177 2018-08-08
296 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-18 0 581 2018-08-08
295 ¼­¿ï °æÈñ´ëÇб³º´¿ø 2018 Kyung Hee Neurosurgery Symposium (ÀÓ¿µÁø ±³¼ö´Ô Á¤³â±â³ä ½ÉÆ÷Áö¿ò) : 2018-08-18 0 1,521 2018-08-08
294 °æ±â ´ëÇÑ°³¿øÀÇÇùÀÇȸ °­¿øÁöȸ ½ÉÆ÷Áö¿ò : 2018-08-18 0 595 2018-08-08
293 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-17 0 1,064 2018-08-08
292 ¼­¿ï °æÈñ´ëÇб³º´¿ø Á¦11ȸ »êºÎÀΰú-¼Ò¾Æû¼Ò³â°ú ¼±»ý´Ôµé°ú ÇÔ²²ÇÏ´Â ¿ù·ÊÁý´ãȸ : 2018-08-17 0 897 2018-08-08
291 °­¿ø °­¿øµµÀÇ»çȸ ÀúÇ÷´çÁõ¿¡ ´ëÇÑ °íÂû : 2018-08-16 0 531 2018-08-08
290 ¼­¿ï ´ëÇѽÅÀåÇÐȸ 2018 Update on CKD-MBD: Phosphorous and Magnesium in health and disease : 2018-09-30 0 1,125 2018-07-28
289 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø °³¿øÀǸ¦ À§ÇÑ ¼Ò¾ÆÁúȯ : 2018-09-29 0 838 2018-07-28
288 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ¿¬±Ø¼º ÀΰÝÀå¾Ö, ÀÇÁ¸¼º ÀΰÝÀå¾Ö : 2018-09-29 0 1,207 2018-07-28
287 ¼­¿ï 2018 ´ëÇÑâ»óÇÐȸ ±³À°½ÉÆ÷Áö¾ö : 2018-09-29 0 605 2018-07-28
1341 | 1342 | 1343 | 1344 | 1345 | 1346 | 1347 | 1348 | 1349 | 1350
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷